Assessment of drug therapy in inflammatory bowel disease.
1982; Wiley; Volume: 14; Issue: 2 Linguagem: Inglês
10.1111/j.1365-2125.1982.tb01957.x
ISSN1365-2125
Autores Tópico(s)Gastrointestinal motility and disorders
ResumoBritish Journal of Clinical PharmacologyVolume 14, Issue 2 p. 159-170 Free Access Assessment of drug therapy in inflammatory bowel disease. HJ Hodgson, HJ HodgsonSearch for more papers by this author HJ Hodgson, HJ HodgsonSearch for more papers by this author First published: August 1982 https://doi.org/10.1111/j.1365-2125.1982.tb01957.xCitations: 18AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References ANDRE, C., DESCOS, L., LANDAIS, P. & FERMANIAN, J. (1980). Laboratory supplementation of Crohn's disease activity index. Lancet, ii, 594–595. BARON, J.H., CONNELL, A.M. & LENNARD-JONES, J.E. (1964). Variation between observers in describing mucosal appearances in proctocolitis. Br. med. J., 1, 89–96. BENDIXEN, G., JARNUM, S. & SOLTOFT, J. (1968). IgG and albumin turnover in Crohn's disease. Scand. J. Gastroenterol., 3, 481–489. BENDIXEN, G., GOLTERMANN, N. & JARNUM, S. (1970). Immunoglobulin and albumin turnover in ulcerative colitis. Scand. J. Gastroenterol., 5, 441–443. BEST, W.R., BECKTEL, J.M., SINGLETON, J.W. & KERN, F. (1976). Development of a Crohn's disease activity index. Gastroenterology, 70, 439–444. BEST, W.R., BECKTEL, J.M. & SINGLETON, J.W. (1979). Rederived values of the eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterology, 77, 843–846. BEST, W.R. & BECKTEL, J.M. (1981). Crohn's disease activity index as a clinical instrument. In Recent Advances in Crohn's Disease, eds A.S. Pena, I.T. Weterman, C.C. Booth & W. Strober pp. 7–11. Amsterdam: Nijhoff. BRAHME, F. & FORK, F.T. (1975). Dynamic aspects of colonic Crohn's disease. Radiology, 15, 463–467. BROBERGER, D. & PERLMANN, P. (1959). Auto antibodies in human ulcerative colitis. J. exp. Med., 110, 657–677. BUCKELL, N.A., GOULD, S.R., DAY, D.W., LENNARDJONES, J.E., & EDWARDS, A.M. (1978). Controlled trial of disodium cromoglycate in persistent ulcerative colitis. Gut, 19, 1140–1143. BURNHAM, W.R., LENNARD-JONES, J.E. & HECKETSWEILER, P. (1979). BCG vaccination in Crohn's disease. Gut, 20, 229–233. CAMPIERI, M., LANFRANCHI, G.A., BAZZOCCHI, G., BRIGNOLA, C., SARBI, F., FRAZER, G., BATTOCCHIA, A., LABO, G. & MONTE, DAL R.R. (1981). Treatment of ulcerative colitis with high dose 5-aminosalicylic acid enemas. Lancet, ii, 270–272. COOKE, W.T., FOWLER, D.C. & COX, E.V. (1958). The clinical significances of seromucoids in regional ileitis and ulcerative colitis. Gastroenterology, 34, 910–919. DEARING, W.H., McGUCKIN, W.F. & ELVEBACK, L.R. (1969). Serum α1-acid glycoprotein in chronic ulcerative colitis. Gastroenterology, 56, 295–303. DE DOMBAL, F.T., BURTON, I.L., CLAMP, S.E. & GOLIGHER, J.C. (1974). Short-term course and prognosis of Crohn's disease. Gut, 15, 435–443. DE DOMBAL, F.T., CLAMP, S.E. & SOFTLEY, A. (1982). International Workshop on Crohn's Disease Activity, Lyon, France. DRONFIELD, M.W. & LANGMAN, M.J.S. (1978). Comparative trial of sulphasalazine and oral sodium cromoglycate in the maintenace of remission in ulcerative colitis. Gut, 19, 1136–1139. FAGAN, E.A., DYCK, R.F., MATON, P.N., HODGSON, H.J.F., CHADWICK, V.S. & PEPYS, M.B. (1982). Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur. J. clin. Invest. (in press). FARMER, R.G., MICHENER, W.M. & SIVAK, D.S. (1981). Studies of family history in inflammatory bowel disease. In Recent Advances in Crohn's Disease. ed. A.S. Pena, I.T. Wetterman, C.C. Booth & W. Strober pp. 213–218. Amsterdam: Nijhoff. FERGUSON, R., ALLAN, R.N. & COOKE, W.T. (1975). A study of the cellular infiltrate of the proximal jejunal mucosa in ulcerative colitis and Crohn's disease. Gut, 16, 205–208. GARDNER, R.C., FEINERMAN, A.E. & KANTROWITZ, P.A. (1978). Seral CEA (carcino/embryonic antigen) blood levels in patients with ulcerative colitis. Am. J. dig. Dis., 23, 129–133. GEFFEN, N., DARNSBOROUGH, A. & DE DOMBAL, P.T. (1968). Radiological signs of ulcerative colitis: assessment of their reliability by means of observer variation studies. Gut, 9, 150–156. GOLDBERG, H.I., CARUTHERS, S.B., NELSON, J.A. & SINGLETON, J.W. (1979). Radiographic findings of the National Co-operative Crohn's Disease Study. Gastroenterology, 77, 925–937. GOODMAN, M.J., SKINNER, J.M. & TRUELOVE, S.C. (1976). Abnormalities in the apparently normal bowel mucus in Crohn's disease. Lancet, i, 275–278. GOULD, S.R., BRASH, A.R., CONNOLLY, M.E. & LENNARD-JONES, J.E. (1981). Studies of prostaglandins and sulphasalazine in ulcerative colitis. Prostaglandins Med., 6, 165–182. HARVEY, R.F. & BRADSHAW, J.M. (1980a). A simple index of Crohn's disease activity. Lancet, i, 514. HARVEY, R.F. & BRADSHAW, J.M. (1980b). Measuring Crohn's disease activity. Lancet, i, 1134. HEATLEY, R.V., CALCRAFT, B.J., RHODES, J., OWEN, E. & EVANS, B.K. (1975). Disodium cromoglycate in the treatment of chronic proctitis. Gut, 16, 559–563. HILL, R.B., KENT, T.H. & HANSEN, R.N. (1979). Clinical usefulness of rectal biopsy in Crohn's disease. Gastroenterology, 77, 938–942. HODGSON, H.J.F. (1980). Immunological aspects of inflammatory bowel disease. In Inflammatory disease of the bowel, eds B.N. BROOKE & A. WILKINSON pp. 38–52. Pitman Medical. HODGSON, H.J.F., POTTER, B.J. & JEWELL, D.P. (1977). The humoral immune system in inflammatory bowel disease. 1. Complement levels. Gut, 18, 749–753. HYWEL-JONES, J., LENNARD-JONES, J.E., MORSON, B.C., CHAPMAN, M., SACKIN, M.J., SNEATH, P.H.A., SPICER, C.C. & CARD, W.I. (1973). Numerical toxonomy and discriminant analysis applied to nonspecific colitis. Quart. J. Med., 42, 715–732. JENSEN, K.B., JARNUM, S., KOUDHAL, G. & KRISTENSEN, M. (1976). Serum orosomucoid in ulcerative colitis. Its relation to clinical activity, protein loss and turnover of albumin and IgG. Scand. J. Gastroenterol., 11, 177–183. LLOYD-STILL, J.D. & GREEN, O.C. (1979). A clinical scoring system for chronic inflammatory bowel disease in children. Dig. Dis. Sci., 24, 620–624. LOCKHART-MUMMERY, H.E. & MORSON, B.C. (1964). Crohn's disease of the large intestine. Gut, 5, 493–509. MATTHEWS, C.M.E. (1957). The theory of tracer experiments with 131 I-labelled plasma proteins. Phys. Med. Biol., 2, 36–50. MAYBERRY, J., RHODES, J. & HUGHES, C.E. (1979). Incidence of Crohn's disease in Cardiff between 1934 and 1977. Gut, 20, 602–608. MILLER, D.S., KEIGHLEY, A.C. & LANGMAN, J.S. (1974). Changing patterns in the epidemiology of Crohn's disease. Lancet, i, 691–693. MISIEWICZ, J.J., LENNARD-JONES, J.E., CONNELL, A.M., BARON, J.H. & JONES, F.A. (1968). Controlled trial of sulphasalazine in maintenance therapy for ulcerative colitis. Lancet, i, 185–188. MONTEIRO, E., FOSSEY, J. & SHINER, M. (1971). Antibacterial antibodies in rectal and colonic mucosa in ulcerative colitis. Lancet, i, 249–251. MORSON, B.C. & DAWSON, I.M.P. (1979). Gastrointestinal pathology. Oxford: Blackwell. MYREN, J., BOUCHIER, I.A.D. & WATKINSON, G. (1978). Inflammatory bowel disease, an OMGE survey. Scand. J. Gastroenterol., 14, Suppl. 6, 1–28. PETO, R., PIKE, M.C., ARMITAGE, P., BRESLOW, N.E., COX, D.R., HOWARD, S.V., MANTEL, N., McPHERSON, K., PETO, J. & SMITH, P.G. (1977). Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Br. J. Cancer, 35, 1–39. PHILPOTTS, R.J., HERMON-TAYLOR, J., TEICH, M.M. & BROOKE, B.N. (1980). A search for persistent virus infection in Crohn's disease. Gut, 21, 202–207. PRESENT, D.H., KORELITZ, B.I., WISCH, N., GLASS, J.L., SACHAR, B.D. & PASTERNACK, B.S. (1980). Treatment of Crohn's disease with 6-mercaptopurine. New Engl. J. Med., 302, 981–987. PRIOR, S., GYDE, S., COOKE, W.T., WATERHOUSE, J.A.H. & ALLAN, R.N. (1981). Mortality in Crohn's disease. Gastroenterology, 80, 307–312. RAMPTON, D.S. & SLADEN, G.E. (1981). Prostaglandin synthesis in ulcerative colitis: flurbiprofen compared with conventional treatment. Prostaglandins, 21, 412–415. SAVERYMUTTU, S.H., PETERS, A.M., LAVENDER, J.P., HODGSON, H.J.F. & CHADWICK, V.S. (1981). III Indium labelled autologous leucocytes in inflammatory bowel disease. Gastroenterology, 80, 1273. SAVERYMUTTU, S.H., PETERS, A.M., LAVENDER, J.P., HODGSON, H.J.F. & CHADWICK, V.S. (1982). Assessment of inflammatory bowel disease using ‘l’Indium labelled autologous leucocytes. Eur. J. clin. Invest. (in press). SHORTER, R.G., CARDOZA, M., SPENCER, R.J. & HUIZENJA, K.A. (1969). Further studies of In vitro cytotoxicity of lymphocytes from patients with ulcerative colitis and Crohn's disease. Gastroenterology, 56, 304–310. SINGER, H.C., ANDERSON, J.G.D., FRISCHER, H. & KIRSNER, J.B. (1971). Familial aspects of inflammatory bowel disease. Gastroenterology, 61, 423–428. SINGLETON, J.W. (1981). International Workshop on Crohn's Disease Activity, Oxford. In discussion. SINGLETON, J.W., LAW, D.H., KELLEY, M.L., HAGOP, S. & STURDEVANT, R.A.L. (1979). National Co-operative Crohn's Disease Study. Results of Drug Treatment. Gastroenterology, 77, 870–882. THAW, P.A. & ALBUTT, E.C. (1980). A critical evaluation of a serum seromucoid assay and its replacement by a serum at acid glycoprotein assay. Ann. clin. Biochem., 140–143. TRUELOVE, S.C. & JEWELL, D.P. (1974). Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet, i, 1067–1070. TRUELOVE, S.C. & WITTS, L.J. (1955). Cortisone in ulcerative colitis: final report on a therapeutic trial. Br. med. J., 2, 1041–1044. VAN HEES, P.A.M., VAN ELTEREN, P.H., VAN LIER, H.J.J. & VAN TONGEREN, J.H.M. (1980). An index of inflammatory activity in patients with Crohn's disease. Gut, 21, 279–286. VAN HEES, P. A.M., VAN LIER, H.J.J., VAN ELTEREN, P.H., DRIESSEN, W.M.M., VAN HOGEZAND, R.A., TEN VELDE, G.P.M., BARKER, J.H. & VAN TONGEREN, J.H.M. (1981). Effect of sulphasalazine in patients with active Crohn's disease. Gut, 22, 404–409. VAN TONGEREN, J.H. & EEKHOUT, A. (1976). Criteria to assess the severity of Crohn's disease and the effect of treatment. In: ed I.T. Weterman, A.S. Pena & C.C. Booth The Management of Crohn's Disease, Amsterdam: Elsevier. WEEKE, B. & JARNUM, S. (1971). Serum concentrations of 19 serum proteins in Crohn's disease and ulcerative colitis. Gut, 12, 297–302. WHITIINGTON, P.E., BARNES, H.V. & BAYLESS, T.M. (1977). Medical management of Crohn's disease in adolescence. Gastroenterology, 70, 439–444. WINSHIP, D.H., SUMMERS, R.W., SINGLETON, J.W., BESK, W.R., BECKTEL, J.M., LENK, L.F. & KERN, F. (1979). National Co-operative Crohn's Disease: Study design and conduct of trial. Gastroenterology, 77, 829–842. Citing Literature Volume14, Issue2August 1982Pages 159-170 ReferencesRelatedInformation
Referência(s)